Pneumococcal carriage in children attending a hospital outpatient clinic in the era of pneumococcal conjugate vaccines in Barcelona

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 3, 2012, Pages 258-262

  Hernandez Bou, Susanna ^a   Garcia Garcia, Juan Jose ^a   Gene, Amadeu ^b   Esteva, Cristina ^b   del Amo, Eva ^b   Muñoz Almagro, Carmen ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Hospital UniversitarioSant Joan de Déu Barcelona   (Spain)

Author keywords

Carriage; Children; Pneumococcal conjugate vaccines; Serotype; Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; ERYTHROMYCIN; LEVOFLOXACIN; PCV 10; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE; UNCLASSIFIED DRUG;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CARRIER; CHILD; CONTROLLED STUDY; DAY CARE; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT DEPARTMENT; PEDIATRIC HOSPITAL; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; OROPHARYNX; OUTPATIENT CLINICS, HOSPITAL; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 84867652316     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.07.005     Document Type: Article

References (31)

1. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediat Infect Dis J 2000, 19:187-195.
2. Bogaert D., de Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154.
3. Calbo E., Díaz A., Cañadell E., Fabrega J., Uriz S., Xercavins M., et al. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococal conjugate vaccine. Clin Microbiol Infect 2006, 9:867-872.
4. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 18th informational supplement, CLSI document (M100-S18) 2008, CLSI, Wayne, PA.
5. Dunais B., Pradier C., Carsenti H., Sabah M., Mancini G., Fontas E., et al. Influence of child care on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae. Pediat Infect Dis J 2003, 22:589-592.
6. Ercibengoa M., Arostegi N., Marimon J.M., Alonso M., Perez-Trallero E. Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the results. BMC Infect Dis 2012, 22:69.
7. Farrell D.J., Klugman K.P., Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of the 7-valent pneumococcal vaccine in the United States. Pediat Infect Dis J 2007, 26:123-128.
8. Finkelstein J.A., Huang S.S., Daniel J., Rifas-Shiman S.L., Kleinman K., Goldmann D., et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics 2003, 112:862-869.
9. Frazao N., Brito-Avo A., Simas C., Saldanha J., Mato R., Nunes S., et al. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediat Infect Dis J 2005, 24:243-252.
10. García de Lomas J., Gimeno C., Millás E., Bermejo M., Lázaro M.A., Navarro D., et al. Antimocrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain. Eur J Clin Microbiol Infect Dis 1997, 16:11-13.
11. Gonzalez B.E., Hulten K.G., Lamberth L., Kaplan S.L., Mason E.O. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediat Infect Dis J 2006, 25:301-306. the U.S. Pediatric Multicenter Pneumococal Surveillance Group.
12. Greenberg D., Broides A., Blancovich I., Peled N., Givon-Lavi N., Dagan R. Relative importance of nasopharyngeal versus oropharyngeal sampling for isolation of Streptococcus pneumoniae and Haemophilus influenzae from healthy and sick individuals varies with age. J Clin Microbiol 2004, 42:4604-4609.
13. Grivea I.N., Panagiotou M., Tsantouli A.G., Syrogiannopoulus G.A. Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day care center attendees in central Greece. Pediat Infect Dis J 2008, 27:519-525.
14. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124:e1-11.
15. Lopez B., Cima M.D., Vazquez F., Fenoll A., Gutierrez J., Fidalgo C., et al. Epidemiological study of Streptococcus pneumoniae carriers in healthy primary-school children. Eur J Clin Microbiol Infect Dis 1999, 18:771-776.
16. Melegaro A., Gay1and N.J., Medley G.F. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol Infect 2004, 132:433-441.
17. Muñoz-Almagro C., Jordan I., Gene A., Latorre C., García-García J.J., Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008, 46:174-182.
18. Muñoz-Almagro C., Esteva C., de Sevilla M.F., Selva L., Gene A., Pallares R. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. J Infect 2009, 59:75-82.
19. O'Brien K.L., Nohynek H. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2003, 22:e1-11. World Health Organization Pneumococcal Vaccine Trials Carriage Working Group.
20. Oteo J., Lázaro E., Abajo F.J., Baquero F., Campos J., Spanish Members of the European Antimicrobial Resistance Surveillance System Trends in antimicrobial resistance in 1968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates. J Clin Microbiol 2004, 42:5571-5577.
21. Petrosillo N., Pantosti A., Bordi E., Spano A., Del Grosso M., Tallarida B., et al. Prevalents, determinants, and molecular epidemiology of Streptococcus pneumoniae isolate colonizing the nasopharynx of healthy children in Rome. Eur J Clin Microbiol Infect Dis 2002, 21:181-188.
22. Principi N., Marchisio P., Schito G.C., Mannelli S., Mannelli S. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Pediat Infect Dis J 1999, 18:517-523.
23. Regev-Yochay G., Raz M., Dagan R., Porat N., Shainberg B., Pinco E., et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis 2004, 38:632-639.
24. Roche A., Heath P.T., Sharland M., Strachan D., Breathnach A., Haigh J., et al. Prevalence of nasopharyngeal carriage of pneumococcus in preschool children attending day care in London. Arch Dis Child 2007, 92:1073-1076.
25. Sa-Leao R., Nunes S., Brito-Avo A., Alves C.R., Carriço J.A., Saldanha J., et al. High rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day-care center revealed in a longitudinal study. J Clin Microbiol 2008, 46:225-234.
26. Sa-Leao R., Nunes S., Brito-Avo A., Frazao N., Simoes A.S., Crisostomo M.I., et al. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect 2009, 15:1002-1007.
27. Sánchez-Tatay D., Arroyo L.A., Tarragó D., Lirola M.J., Porras A., Fenoll A., et al. Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children. Clin Microbiol Infect 2008, 14:797-801.
28. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., Dagan R. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediat Infect Dis J 2008, 28:277-281.
29. Techasaensiri C., Messina A.F., Katz K., Ahmad N., Huang R., McCracken G.H. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediat Infect Dis J 2010, 29:294-300.
30. Varon E., Levy C., De la Rocque F., Boucherat M., Deforche D., Podglajen I., et al. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarralis in children with respiratory tract infections. Clin Infect Dis 2000, 31:477-481.
31. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein- polysaccharide conjugates vaccine. N Engl J Med 2003, 348:1737-1746.